TERN-601
Phase 2Completed 1 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Overweight or Obesity
Conditions
Overweight or Obesity
Trial Timeline
Mar 7, 2025 → Sep 19, 2025
NCT ID
NCT06854952About TERN-601
TERN-601 is a phase 2 stage product being developed by Terns Pharmaceuticals for Overweight or Obesity. The current trial status is completed. This product is registered under clinical trial identifier NCT06854952. Target conditions include Overweight or Obesity.
What happened to similar drugs?
1 of 20 similar drugs in Overweight or Obesity were approved
Approved (1) Terminated (0) Active (19)
Hype Score Breakdown
Clinical
12
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06854952 | Phase 2 | Completed |
Competing Products
20 competing products in Overweight or Obesity